Risk Factors for Cyclosporine-Induced Nephropathy in Patients with Autoimmune Diseases
Open Access
- 18 June 1992
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (25), 1654-1660
- https://doi.org/10.1056/nejm199206183262502
Abstract
Cyclosporine is an immunosuppressive drug that is used to treat patients with autoimmune disease as well as patients who have received allografts. The drug can cause renal damage, but the incidence of and risk factors for nephropathy in patients treated with cyclosporine for autoimmune or inflammatory diseases are not known.This publication has 20 references indexed in Scilit:
- Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulinDiabetes, 1990
- Kidney biopsies in control or cyclosporin Atreated psoriatic patients.British Journal of Dermatology, 1990
- Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial GroupDiabetes, 1988
- Factors Associated with Early Remission of Type I Diabetes in Children Treated with CyclosporineNew England Journal of Medicine, 1988
- Cyclosporin-associated nephropathy in patients with autoimmune diseasesKlinische Wochenschrift, 1988
- Combined steroid-cyclosporin treatment of chronic autoimmune diseasesKlinische Wochenschrift, 1987
- Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporineArchives of Internal Medicine, 1986
- Renal Histopathologic Alterations in Patients Treated with Cyclosporine for UveitisNew England Journal of Medicine, 1986
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- A Radioimmunoassay to Measure Cyclosporin a in Plasma and Serum SamplesJournal of Immunoassay, 1981